logo True scholar network
Back to Top
Visit Website

Inflammopharmacology (Inflammopharmacology)

Publisher :

Springer Nature Switzerland AG & Brill

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Pharmacology
  • Inflammation
  • Rheumatology

    • +5

e-ISSN :

1568-5608

Issue Frequency :

Quarterly

Impact Factor :

5.3

p-ISSN :

0925-4692

Est. Year :

1991

Mobile :

41417473600

DOI :

YES

Country :

Switzerland

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

editor@inflammopharmacology.com

Journal Descriptions

Inflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. Compares different inflammatory states and their causes. Examines the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. Offers in-depth coverage of Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals. Places particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs. Focuses on the safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics.


Inflammopharmacology (Inflammopharmacology) is :

International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Inflammation, Rheumatology, Gastroenterology, Neuropharmacology, Toxicology, Pain Management, Drug Safety , Online or Print, Quarterly Journal

UGC Approved, ISSN Approved: P-ISSN - 0925-4692, E-ISSN - 1568-5608, Established in - 1991, Impact Factor - 5.3

Provide Crossref DOI

Indexed in Scopus, WoS, PubMed

Not indexed in DOAJ, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
PubMed

+5 More

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile